SOURCE: Industrial Info Resources

Industrial Info Resources

September 10, 2014 06:30 ET

New England Takes $8.4 Billion Slice of Pharmaceutical-Biotech Capital/MRO Investment Pie, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - Sep 10, 2014) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- There are nearly 1,350 active Pharmaceutical-Biotech Industry capital and maintenance (MRO) projects in North America, representing a total investment value (TIV) of $61 billion. According to a recent analysis of Industrial Info's Pharmaceutical-Biotech Industry database, the New England region is at the top, accounting for an $8.4 billion portion of that spending for 126 projects.

Within this article: Details on projects from leading companies, such as Novartis (NYSE:NVS), The Jackson Laboratory and Gilbane, including investment values and schedules.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    William Ploch